Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intercontinental Exchange
ICE
|
+$98M |
| 2 |
Ferguson
FERG
|
+$83.1M |
| 3 |
Bank of America
BAC
|
+$80.9M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$74.4M |
| 5 |
Nike
NKE
|
+$63.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AutoNation
AN
|
+$61.6M |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$51.6M |
| 3 |
JPMorgan Chase
JPM
|
+$51.3M |
| 4 |
Phillips 66
PSX
|
+$47.7M |
| 5 |
S&P Global
SPGI
|
+$47.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.47% |
| 2 | Technology | 13.54% |
| 3 | Industrials | 9.36% |
| 4 | Healthcare | 8.37% |
| 5 | Consumer Discretionary | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Omeros
OMER
$1.4B
| $380K | ﹤0.01% |
138,100
+100,400
| +266% | +$340K |
|
1527
Protagonist Therapeutics
PTGX
$9.74B
| $380K | ﹤0.01% |
48,032
+34,332
| +251% | +$415K |
|
1528
Alphatec Holdings
ATEC
$1.44B
| $377K | ﹤0.01% |
57,631
-88,526
| -61% | -$816K |
|
|
AEL
1529
DELISTED
American Equity Investment Life Holding Company
AEL
| $377K | ﹤0.01% |
10,300
-12,918
| -56% | -$492K |
|
1530
Scholastic
SCHL
$773M
| $376K | ﹤0.01% |
10,457
-1,043
| -9% | -$38.5K |
|
1531
Sea Limited
SE
$75.4B
| $376K | ﹤0.01% |
5,617
-2,778
| -33% | -$237K |
|
|
AGAC
1532
DELISTED
African Gold Acquisition Corp
AGAC
| $376K | ﹤0.01% |
38,393
+10
| +0% | +$98 |
|
|
FOLD
1533
DELISTED
Amicus Therapeutics
FOLD
| $372K | ﹤0.01% |
34,639
-156,861
| -82% | -$1.29M |
|
|
PHIC
1534
DELISTED
Population Health Investment Co., Inc. Class A Ordinary Share
PHIC
| $372K | ﹤0.01% |
37,672
+12,446
| +49% | +$123K |
|
1535
Entergy
ETR
$49.6B
| $371K | ﹤0.01% |
6,588
-298,108
| -98% | -$17.5M |
|
1536
iShares US Infrastructure ETF
IFRA
$4.22B
| $371K | ﹤0.01% |
10,900
| – | – |
|
1537
Rithm Capital
RITM
$5.68B
| $370K | ﹤0.01% |
39,700
+15,700
| +65% | +$165K |
|
1538
ProShares Short Bitcoin Strategy ETF
BITI
$111M
| $369K | ﹤0.01% |
+1,680
| New | +$342K |
|
1539
Cardlytics
CDLX
$25.2M
| $368K | ﹤0.01% |
+1,650
| New | +$553K |
|
1540
Oramed Pharmaceuticals
ORMP
$217M
| $368K | ﹤0.01% |
80,400
+67,400
| +518% | +$360K |
|
1541
Trupanion
TRUP
$1.4B
| $368K | ﹤0.01% |
6,100
-10,521
| -63% | -$716K |
|
|
LOGC
1542
DELISTED
ContextLogic
LOGC
| $368K | ﹤0.01% |
7,677
+5,956
| +346% | +$322K |
|
1543
Arrowhead Research
ARWR
$12.6B
| $365K | ﹤0.01% |
10,361
-7,239
| -41% | -$272K |
|
1544
Rocket Lab Corp
RKLB
$42.8B
| $363K | ﹤0.01% |
95,700
+72,254
| +308% | +$425K |
|
1545
Ormat Technologies
ORA
$6.53B
| $361K | ﹤0.01% |
4,600
-13,107
| -74% | -$1.03M |
|
1546
Sibanye-Stillwater
SBSW
$8.87B
| $361K | ﹤0.01% |
+36,300
| New | +$474K |
|
|
CD
1547
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $361K | ﹤0.01% |
+46,515
| New | +$300K |
|
1548
Traeger
COOK
$160M
| $360K | ﹤0.01% |
+1,694
| New | +$472K |
|
|
MZTI
1549
The Marzetti Company
MZTI
$3.2B
| $360K | ﹤0.01% |
+2,800
| New | +$383K |
|
1550
Standard Motor Products
SMP
$838M
| $360K | ﹤0.01% |
8,000
-600
| -7% | -$24.9K |
|
Similar funds
Steve Schonfeld's Q2 2022 Portfolio in Review
As of Q2 2022, Steve Schonfeld held 3,357 positions worth $10.3B, down 7.2% from $11.1B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Steve Schonfeld deployed $969M of net new capital in Q2 2022, opening 810 new positions and adding to 937 existing holdings. Its largest new stake was Nike: 535,587 shares worth $54.7M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AutoNation, an estimated $61.6M trimmed.
- Steve Schonfeld's largest Q2 2022 buy was Nike: 535,587 shares worth $54.7M.
- Steve Schonfeld added most to Intercontinental Exchange in Q2 2022, an estimated $98M increase.
- Steve Schonfeld's biggest Q2 2022 reduction was AutoNation, cutting an estimated $61.6M.
- Steve Schonfeld fully exited RH in Q2 2022, selling an estimated $38.8M.
- Steve Schonfeld's ten largest holdings make up 9.3% of its $10.3B portfolio in Q2 2022.
- Steve Schonfeld opened 810 new positions and closed 885 in Q2 2022.
- Steve Schonfeld's portfolio value fell 7.2% quarter-over-quarter to $10.3B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.